These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164 [TBL] [Abstract][Full Text] [Related]
6. Newer directions in vaccine development and utilization. Hilleman MR J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958 [TBL] [Abstract][Full Text] [Related]
9. Recombinant vaccinia viruses as new live vaccines. Smith GL; Mackett M; Moss B Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668 [No Abstract] [Full Text] [Related]
10. [Antiherpetic cultural inactivated divaccine (experience in its preparation and study of its therapeutic effectiveness)]. Bikbulatov RM; Demidova SA; Alekseeva AA; Cheglakov IuA; Kozlova VI Sov Med; 1983; (3):50-4. PubMed ID: 6304919 [No Abstract] [Full Text] [Related]
11. Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines. Gough NM; Murray K J Mol Biol; 1982 Nov; 162(1):43-67. PubMed ID: 6296407 [No Abstract] [Full Text] [Related]
12. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase]. Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422 [No Abstract] [Full Text] [Related]
13. Correlation of virus polypeptide structure with attenuation of poliovirus type 1. Milstien JB; Walker JR; Eron LJ J Virol; 1977 Sep; 23(3):811-5. PubMed ID: 197272 [TBL] [Abstract][Full Text] [Related]
17. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Smith GL; Mackett M; Moss B Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382 [TBL] [Abstract][Full Text] [Related]
18. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Oxford JS; McGeoch DJ; Schild GC; Beare AS Nature; 1978 Jun; 273(5665):778-9. PubMed ID: 661986 [No Abstract] [Full Text] [Related]
19. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Da Costa XJ; Jones CA; Knipe DM Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6994-8. PubMed ID: 10359827 [TBL] [Abstract][Full Text] [Related]
20. Genetically engineered poxviruses: a novel approach to the construction of live vaccines. Paoletti E; Weinberg RL; Davis SW; Davis M Vaccine; 1984 Sep; 2(3):204-8. PubMed ID: 6099648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]